Maine Biotechnology Services, Inc. (MBS) is a custom antibody service partner located in Portland, Maine. MBS was founded in 1990 by Dr. Joseph Chandler and continues to be wholly owned and operated in Maine. MBS has the experience necessary to be your provider for all antibody based developments. The MBS technical team applies comprehensive antibody expertise to immunogen design or recombinant antigen expression, and generation of specific antibodies for your application. MBS has a refined tool set, built over 25 years in the business to ensure the efficient selection of antibodies with the most potential to work in our customer’s applications. Both in vivo and in vitro antibody production are provided with tailored purification protocols.
MBS scientists can then take antibodies produced at MBS a step further into assay method development. They use technical proficiency and quality project management to aid our customers in the implementation of assays to be performed in their lab, or to be transferred to a third party for validation. In 2001, MBS became a cGMP facility to solidify our commitment to quality and our place as a bulk supplier to IVD companies. In 2002, MBS became 1774 EU/2002 approved allowing us to continue sending our products into the European Union.
We invite you to browse the MBS website and learn more about the value you we can bring as an extension of your lab. In addition to our custom services, we invite you to browse our antibody products, developed by MBS R&D and produced in house for maximum quality control and pricing flexibility.